BIOVALENCE SDN BHD has a total of 16 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Singapore, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SYMBIONTICS INC, JCR PHARMACEUTICALS CO LTD and CNJ HOLDINGS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Singapore | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Climate change adaptation technologies | |
#7 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Abu Bakar Ag Muhammad Sagaf | 15 |
#2 | Ung Eng Huan | 15 |
#3 | Sekaran Shamala Devi K C | 12 |
#4 | Rothan Hussin A | 12 |
#5 | Sagaf Abu Bakar Ag Muhammad | 1 |
#6 | Huan Ung Eng | 1 |
Publication | Filing date | Title |
---|---|---|
US2015173333A1 | Rapid specific pathogen free animal | |
AU2013281395A1 | Dosage regime of fusion compounds | |
SG11201408280YA | Anticancer treatment |